These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 452907)

  • 1. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(1):13-20. PubMed ID: 452907
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.
    Ringdahl B; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(4):297-304. PubMed ID: 1199731
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
    Resul B; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(3):161-5. PubMed ID: 484249
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1978; 15(4):255-63. PubMed ID: 726907
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.
    Lindgren S; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):503-6. PubMed ID: 1217504
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbom R
    Acta Pharm Suec; 1973 Dec; 10(6):435-40. PubMed ID: 4773112
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylene compounds of potential pharmacological value. XXXVI. N-(4-tert-Amino-2-butynyl)-substituted 2(3H)-thiazolones and 2(3H)-oxazolones.
    Moses P; Dahlbom R
    Acta Pharm Suec; 1978; 15(3):175-80. PubMed ID: 716951
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
    Svensson U; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclopropane analogues to acetylenic oxotremorine antagonists.
    Grundström K; Dahlbom R
    Acta Pharm Suec; 1972 Nov; 9(5):491-8. PubMed ID: 4650125
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
    Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ring.
    Ringdahl B; Muhi-Eldeen Z; Ljunggren C; Karlén B; Resul B; Dahlbom R
    Acta Pharm Suec; 1979; 16(2):89-94. PubMed ID: 474169
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
    Svensson U; Hacksell U; Dahlbom R
    Acta Pharm Suec; 1978; 15(1):67-70. PubMed ID: 645369
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.
    Amstutz R; Ringdahl B; Karlén B; Roch M; Jenden DJ
    J Med Chem; 1985 Dec; 28(12):1760-5. PubMed ID: 2933518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselectivity of some oxotremorine antagonists containing two chiral centres.
    Ringdahl B; Resul B; Dahlbom R
    J Pharm Pharmacol; 1979 Dec; 31(12):837-9. PubMed ID: 43369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylene compounds of potential pharmacological value. VII. 4-Dialkylamino-2-butynyl ethers.
    Dahlbom R; Karlén B; Lindquist A
    Acta Pharm Suec; 1966 Jun; 3(3):187-96. PubMed ID: 5967304
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylene compounds of potential pharmacological value. IX. N-(4-dialkylamino-2-butynyl)-substituted carboxylic and sulphonic acid amides.
    Dahlbom R; Karlén B; Lindquist A; George R; Jenden DJ
    Acta Pharm Suec; 1967 Sep; 4(4):247-52. PubMed ID: 6082975
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and pharmacological properties of 1,3 and 5-substituted 2-pyrrolidinones.
    Gorczyca M; Malawska B; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1978; 30(5):675-83. PubMed ID: 751008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.